Malignancies in organ transplant recipients |
| |
Authors: | Hoshida Yoshihiko Aozasa Katsuyuki |
| |
Affiliation: | Department of Pathology, Osaka University Medical School, Osaka, Japan. hoshida@molpath.med.osaka-u.ac.jp |
| |
Abstract: | The development of cancer in organ transplant recipients is well known; depressed immunosurveillance induced by the use of immunosuppressive agents for prevention of rejection is a causative factor. The types of malignancies in renal transplant patients vary geographically and are influenced by the type of immunosuppressant used. In the present study in Japan, malignancies had developed in 2.6% of renal transplant recipients; the observed number/expected number ratio was 2.78. For the primary sites, the relative risk in Japan was quite different from that in Western countries, with a lower frequency of skin cancer, an absence of Kaposi's sarcoma and higher frequencies of renal and thyroid cancer in Japan. Epstein-Barr virus is an oncogenic virus causing lymphoproliferative disorders in immunocompromised hosts. In renal transplant recipients, who usually receive hemodialysis before transplantation, human T lymphotrophic virus (HTLV)-1 is also oncogenic and causes adult T-cell leukemia/lymphoma. The HTLV-1 in donor blood might be transmitted to transplant recipients via transfusion during hemodialysis. The epidemiology and characteristics of representative malignancies in transplant recipients are described, with a review of pertinent literature. |
| |
Keywords: | acquired cystic disease of the kidney adult T cell lymphoma cancer epidemiology Epstein–Barr virus hemodialysis malignancy p53 gene mutations post-transplantation lymphoproliferative disorder renal cancer transplantation |
本文献已被 PubMed 等数据库收录! |
|